Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 23

Trial Status

Completed5
Terminated1

Role Distribution

Principal Investigator4
Other Roles2
PI Rate67%

Activity Timeline

Clinical Trials (6)

NCT00004251Phase 2Completed
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
Endometrial Cancer
StudychairStart date: 2000-01-19
NCT00188578Phase 1/2Completed
Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)
Cervix NeoplasmsUterine NeoplasmsVaginal Neoplasms
Principalinvestigator
NCT00895349Not ApplicableCompleted
Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)
AdenocarcinomaAdenosquamous CarcinomaCervical Cancer+1 more
Principalinvestigator
NCT02724501Completed
Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer
Endometrial Neoplasms
Principalinvestigator

Research Network

Collaboration Network

8 collaborators·22 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Karen Gulenchyn, MD

Hamilton Health Sciences Centre

Moderately Similar
1 trials

Shared therapeutic areas:

AdenocarcinomaCarcinoma, AdenosquamousCancer of the Uterine Cervix+1 more

Worked with same sponsors:

Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term Care
Collaborated on 1 trial
Similarity Score44%

Greg Pond, PhD

Ontario Clinical Oncology Group/McMaster University, Department of Oncology

Moderately Similar
1 trials

Shared therapeutic areas:

AdenocarcinomaCarcinoma, AdenosquamousCancer of the Uterine Cervix+1 more

Worked with same sponsors:

Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term Care
Collaborated on 1 trial
Similarity Score44%

Mark Levine, MD

Ontario Clinical Oncology Group/McMaster University, Department of Oncology

Moderately Similar
1 trials

Shared therapeutic areas:

AdenocarcinomaCarcinoma, AdenosquamousCancer of the Uterine Cervix+1 more

Worked with same sponsors:

Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term Care
Collaborated on 1 trial
Similarity Score44%

Douglas Coyle, PhD

University of Ottawa Epidemiology & Community Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

AdenocarcinomaCarcinoma, AdenosquamousCancer of the Uterine Cervix+1 more

Worked with same sponsors:

Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term Care
Collaborated on 1 trial
Similarity Score44%

Laurie Elit, MD

Juravinski Cancer Centre, Canada

Moderately Similar
1 trials

Shared therapeutic areas:

AdenocarcinomaCarcinoma, AdenosquamousCancer of the Uterine Cervix+1 more

Worked with same sponsors:

Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term Care
Collaborated on 1 trial
Similarity Score44%

Mostafa Atri, MD

University Health Network, Toronto

Moderately Similar
1 trials

Shared therapeutic areas:

AdenocarcinomaCarcinoma, AdenosquamousCancer of the Uterine Cervix+1 more

Worked with same sponsors:

Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term Care
Collaborated on 1 trial
Similarity Score44%

Michael Milosevic, MD

University Health Network, Princess Margaret Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical NeoplasmsUterine Neoplasms+1 more

Worked with same sponsors:

Princess Margaret Hospital, CanadaUniversity Health Network, Toronto
Collaborated on 1 trial
Similarity Score44%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Breast CancerCancer of the Uterine CervixCancer of Head and Neck+1 more
Similarity Score9%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerCancer of the Uterine CervixAdenocarcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Cancer of Head and NeckProstate CancerSarcoma
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT00004251Phase 2StudyChair

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

Endometrial Cancer
Completed
NCT00004261Phase 1StudyChair

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Breast CancerCervical CancerHead and Neck Cancer+2 more
Terminated
NCT00152828Phase 1/2PrincipalInvestigator

Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix

Cervix Neoplasms
Completed
NCT00188578Phase 1/2PrincipalInvestigator

Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)

Cervix NeoplasmsUterine NeoplasmsVaginal Neoplasms
Completed
NCT00895349Not ApplicablePrincipalInvestigator

Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)

AdenocarcinomaAdenosquamous CarcinomaCervical Cancer+1 more
Completed
NCT02724501PrincipalInvestigator

Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer

Endometrial Neoplasms
Completed

All 6 trials loaded